07:00 , Jul 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Polymerase (DNA directed), delta 2, regulatory subunit 50kDa (POLD2); cytochrome c, somatic (CYCS); metallothionein 1A (MT1A; MTC); aldo-keto reductase family 1, member C3...
07:00 , Apr 6, 1998 |  BioCentury  |  Finance

Muscle up

Ferrari said Muse could benefit from an increase in consumer awareness of ED that could be brought about through Pfizer's marketing. "The Pfizer marketing launch will drive people into doctors' offices and the doctors will...
07:00 , May 1, 1995 |  BioCentury  |  Product Development

Neurox's inroad into untreatable pain

Neurex's inroad into untreatable pain Neurex Inc. said it has seen positive early results in what is potentially the first new class of analgesics in 50 years. The new drug, SNX-111 , appears to be...